This article is more than 5 years old. Information may no longer be current.

VIDEO: Iluvien safety data show low incisional surgery rates

ByCaesar Luo, MD, FACS

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

VANCOUVER, British Columbia — Caesar Luo, MD, FACS, discusses global safety data for Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg) at the Association for Research in Vision and Ophthalmology meeting. In phase 4 post-market studies, the rate of IOP-related incisional surgery was “extremely low,” he said.